
Homology Model of Antimalarial Compounds
Author(s) -
M Madhubhushan,
S Seshaiah,
Jogu Chandrudu,
Rashmi Sagar
Publication year - 2018
Publication title -
international journal of novel trends in pharmaceutical sciences
Language(s) - English
Resource type - Journals
ISSN - 2277-2782
DOI - 10.26452/ijntps.v8i2.1315
Subject(s) - plasmodium falciparum , malaria , drug discovery , pharmacology , biology , medicine , traditional medicine , bioinformatics , immunology
Jungle fever is one of the most frightening impossible to resist illnesses to eradicate, particularly in Sub-Saharan Africa. Plasmodium falciparum leftovers the maximum pervasive intestinal illness parasite in the world, representing 216 million assessed instances in 2016. The drugs obstruction of intestinal sickness parasite has caused the want and quest for brand spanking new compound platforms that have novel techniques of interest and can act through new protein targets. One in every of such protein focuses in P falciparum is the adenylosuccinate lyase (ADSL), that is a tremendous compound in purine digestion. Benzimidazole subsidiaries have been broadly applied as of late due to their huge scope of pharmacological physical activities including antimalarial, antileishmanial, analgesics, anticancer, antitumour, antimicrobial, mitigating, anti-hepatitis C infection, antihelmintic, antibacterial and antitrypanosomal physical games. Albeit some benzimidazole subordinates have been orchestrated and shaped into monetarily handy medications, little is concept approximately the plan of the layout as an inhibitor towards P falciparum ADSL (PfADSL).